193. Prader-Willi syndrome Clinical trials / Disease details
Clinical trials : 111 / Drugs : 120 - (DrugBank : 30) / Drug target genes : 51 - Drug target pathways : 103
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ChiCTR2000039618 | 2020-12-01 | 2020-11-03 | Diagnostic accuracy of RNA molecular markers in Prader Willi syndrome | Diagnostic accuracy of RNA molecular markers in Prader Willi syndrome | Prader-Willi syndrome | Gold Standard:Methylation specific multiplex ligation probe amplification (MS-MLPA) combined with chromosome G-banding karyotype analysis and array comparative genomic hybridization (array CGH).;Index test:Detection of ribonucleic acid molecular markers.; | Children's Hospital Affiliated to Medical College of Zhejiang University | NULL | Recruiting | Both | Target condition:20;Difficult condition:0 | China |